SBC Medical Group Holdings Incorporated EBIT

As of the most recent data (June 2026), SBC shows a EBIT of $14T. That compares with $15T in the prior-year period — down 4.7% year over year. That is above the sector sector average of $-25M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBC's EBIT is now $14T (was $15T) — a 4.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether SBC Medical Group Holdings Incorporated is outperforming or lagging.

The its sector sector average EBIT is about $-25M. SBC Medical Group Holdings Incorporated is at $14T, which is higher that average. That is roughly 54740992.1% above the sector mean. Use the comparison chart on this page to see how SBC stacks up against individual peers as well.

Tracking SBC's ebit over time shows whether SBC Medical Group Holdings Incorporated is scaling, shrinking, or reshaping that part of the business. The current reading is $14T That compares with $15T in the prior-year period — down 4.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has SBC Medical Group Holdings Incorporated's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $14T) with ownership activity and broader fundamentals.